Remember that much-hyped story about an Australian tech entrepreneur using ChatGPT, Grok, and other AI tools to craft a personalized cancer vaccine for his dog? Well, surprise: he's launched a startup.
That entrepreneur is Paul Conyngham, who says he is launching Gamgee to offer "personalised mRNA cancer vaccines for dogs." But his ambitions go well beyond dogs - and pets - with Gamgee's website promising the company will harness AI and genetics to develop personalized treatments for a range of diseases and species, including humans.
At the center of Gamgee's origin story is Rosie, Conyngham's Staffordshire bull terrier-Shar Pei mix, who …
This article was originally published by The Verge and written by Robert Hart.
Read original article on The Verge